Microcalorimetric evaluation of the in vitro compatibility of amoxicillin/clavulanic acid and ampicillin/sulbactam with ciprofloxacin

Journal of Pharmaceutical and Biomedical Analysis

Volumn 36, Issue 2, 2004, Pages 295-307

  Chadha, R ^a   Kashid, N ^a   Jain, D V S ^b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Amoxicillin trihydrate; Ampicillin trihydrate; Ciprofloxacin hydrochloride; Enthalpy of solution; Potassium clavulanate; Solution calorimetry; Sulbactum sodium; Ternary interaction parameter

Indexed keywords

AMOXICILLIN; AMPICILLIN; CIPROFLOXACIN; CLAVULANATE POTASSIUM; SULBACTAM;

AB INITIO CALCULATION; ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG SCREENING; ENTHALPY; HYDROGEN BOND; IN VITRO STUDY; MICROCALORIMETRY; PH; PRIORITY JOURNAL;

ALGORITHMS; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; AMPICILLIN; ANTI-BACTERIAL AGENTS; BUFFERS; CALORIMETRY; CIPROFLOXACIN; DRUG INCOMPATIBILITY; DRUG THERAPY, COMBINATION; HYDROGEN-ION CONCENTRATION; PENICILLINS; SOLUTIONS; SULBACTAM; THERMODYNAMICS;

EID: 5644232901     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.06.003     Document Type: Article

References (38)

1. Freifeld A., Archigiani D., Walsh T., Chanock S., Lewis L., Hiemenz J., Hiemenz S., Hicks J.E., Gill V., Steinberg S.M., Pizzo P.A. New Eng. J. Med. 341:1999;305-311
2. Kern W.V., Cometta A., Bock R., Langenaeken J., Paesmans M., Gaya H. New Eng. J. Med. 341:1999;312-318
3. Eyjolfsson R. Drug Dev. Ind. Pharm. 24:1998;797-798
4. Blanco-Fuente H.B., Esteban-Fernandez J., Otero-Espinar F.J. Chem. Pharm. Bull. 50:2002;40-46
5. Joshi B.V., Patil V.B., Pokharkar V.B. Drug Dev. Ind. Pharm. 28:2002;687-694
6. Jain D.V.S., Kashid N., Kapoor S., Chadha R. Int. J. Pharm. 201:2000;1-6
7. Chadha R., Kashid N., Jain D.V.S. J. Pharm. Biomed. Anal. 30:2003;1515-1522
8. Col N.F., O'Connor R.W. Rev. Infec. Dis. 9(Suppl. 3):1987;S232-S243
9. Barriere S.L. Drug Intell. Clin. Pharm. 19:1985;278-281
10. Mandell L.A., Bergeron M.G., Gribble M.J., Jewesson P.J., Low D.E., Marrie T.J., Nicolle L.E. Can. J. Infect. Dis. 6:1995;306-315
11. Jewesson P. Pharamcoecon. 5:1994;341-344
12. Fuchs P.C., Barry A.L. J. Reprod. Med. 35:1990;317-321
13. Campoli-Richards D.M., Brogden R.N. Drugs. 33:1987;577-609
14. Foulds G. Rev. Infect. Dis. 8:1986;S503-S511
15. Jacobs M.R., Aronoff S.C., Johenning S., Shlaes D.M., Yamabe S. Antimicrob. Agents Chemother. 29:1986;980-985
16. B. Slocombe, A.S. Beale, R.J. Boom, K.E. Griffin, R.J. Masters, R. Sutherland, et al., Antibacterial activity in vitro and in vivo of amoxicillin in the presence of clavulanic acid, in: McGraw-Hill (Ed.), Progress and Perspectives on Beta-Lactamase Inhibition: a Review of Aug-mentin, Post-Graduate Medicine, Custom Communications, New York, 1984, pp. 29-49.
17. Janknegt R., Schrouff G.G., Hooymans P.M., Hermens W.J., Lohman J.J. DICP. 23:1989;91-92
18. Melonakos T.K. Ann. Pharmacother. 30:1996;87
19. Elmore R.L., Contois M.E., Kelly J., Noe A., Poirier A. Clin. Ther. 18:1996;246-255
20. Indrayanto G., Sa T.K., Widjaja S. JAOAC Int. 83:2000;1493-1496
21. Aghazadeh A., Kazemifard G. J. Pharm. Biomed. Anal. 25:2001;325-329
22. Tsou T.L., Wu J.R., Young C.D., Wang T.M. J. Pharm. Biomed. Anal. 15:1997;1197-1205
23. Pajchel G., Pawlowski K., Tyski S. J. Pharm. Biomed. Anal. 29:2002;75-81
24. Mahgoub H., Aly F.A. J. Pharm. Biomed. Anal. 17:1998;1273-1278
25. Anon., Pharm. J. 245 (1990) 183-184.
26. Gibson S.H.M., Rowe C., White E.F.T. Int. J. Pharm. 48:1988;113-117
27. G.D. Christian, in: Analytical Chemistry, 4th ed., John Wiley & Sons, Inc., New York, 1986, pp. 143-145.
28. Haginaka J., Wakai J., Yasuda H., Uno T., Nakagawa T. Chem. Pharm. Bull. 33:1985;2461-2468
29. Tsuji A., Nakashima E., Hamano S., Yamana T. J. Pharm. Sci. 67:1978;1059-1066
30. Haginaka J., Nakagawa T., Uno T. Chem. Pharm. Bull. 29:1981;3334-3341
31. W.O. Foye, T.L. Lemke, D.A. Williams, Principles of Medicinal Chemistry, 4th ed., Williams & Wilkins, Philadelphia, 1995, 950 pp.
32. Yu X., Zipp G.L., Ray Davidson G.W. III Pharm. Res. 11:1994;522-527
33. Sulbactam Sodium, Merck Index, 12th ed., Merck Research Laboratories, Division of Merck & Co., Inc., New Jersey, 1996, pp. 1518-1519.
34. J. Mortaon, M. Nguyen, M. Passarelli, S. Riley, U. Tarzi, N. Tran, H. Vu, Group T, Case Study 2, Part I (2001) 1-6.
35. Redlich O., Kister A.T. Ind. Eng. Chem. 40:1948;345-348
36. Brock C.P., Duncan L.L. Chem. Mater. 6:1994;1307-1312
37. Trissel L.A., Tramonte S.M., Grilley B.J. Am. J. Hosp. Pharm. 48:1991;988-992
38. Phipps M.A., Mackin L.A. PSTT. 3:2000;9-17